CD276 and brain neoplasm: A broad characterization of the five potential CAR-T cell targets IL13Rα2, HER2, EPHA2, B7-H3 and GD2, investigated in 49 patient-derived orthotopic xenografts of pediatric brain tumors, was performed by Haydar et al. [106] (Table 3).